These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2516958)

  • 21. The cholinergic system in Alzheimer's disease and dementia with Lewy bodies: from animal models to neuropathological data.
    Liberini P
    Funct Neurol; 1997; 12(3-4):153-7. PubMed ID: 9218969
    [No Abstract]   [Full Text] [Related]  

  • 22. Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease.
    Pearce BR; Palmer AM; Bowen DM; Wilcock GK; Esiri MM; Davison AN
    Neurochem Pathol; 1984-1985 Winter; 2(4):221-32. PubMed ID: 6085697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nature and mechanisms of cholinergic-monoaminergic interactions in the brain.
    Butcher LL
    Life Sci; 1977 Nov; 21(9):1207-26. PubMed ID: 337018
    [No Abstract]   [Full Text] [Related]  

  • 24. Hibernation model of tau phosphorylation in hamsters: selective vulnerability of cholinergic basal forebrain neurons - implications for Alzheimer's disease.
    Härtig W; Stieler J; Boerema AS; Wolf J; Schmidt U; Weissfuss J; Bullmann T; Strijkstra AM; Arendt T
    Eur J Neurosci; 2007 Jan; 25(1):69-80. PubMed ID: 17241268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis of Alzheimer's disease].
    Delacourte A
    Ann Biol Clin (Paris); 1998; 56(2):133-42. PubMed ID: 9754238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GABA(A) receptors in aging and Alzheimer's disease.
    Rissman RA; De Blas AL; Armstrong DM
    J Neurochem; 2007 Nov; 103(4):1285-92. PubMed ID: 17714455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation].
    Dubois B; Hauw JJ; Ruberg M; Serdaru M; Javoy-Agid F; Agid Y
    Rev Neurol (Paris); 1985; 141(3):184-93. PubMed ID: 4001706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alzheimer's disease.
    Petrie WM
    Compr Ther; 1985 Jul; 11(7):38-43. PubMed ID: 2863031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GABAergic drugs and Alzheimer's disease.
    Limon A; Reyes-Ruiz JM; Miledi R
    Future Med Chem; 2011 Feb; 3(2):149-53. PubMed ID: 21428809
    [No Abstract]   [Full Text] [Related]  

  • 30. [Abnormalities of neurotransmitters in Alzheimer's disease. Neurotransmitters and receptors].
    Ogawa N; Sato H
    Nihon Rinsho; 1988 Jul; 46(7):1496-501. PubMed ID: 2851665
    [No Abstract]   [Full Text] [Related]  

  • 31. Alzheimer's disease.
    Gottfries CG
    Gerontology; 1986; 32 Suppl 1():98-101. PubMed ID: 2874102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alzheimer's disease and serotonin: a review.
    Whitford GM
    Neuropsychobiology; 1986; 15(3-4):133-42. PubMed ID: 3785643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological markers in mental disorders: post-mortem studies.
    Rossor M
    J Psychiatr Res; 1984; 18(4):457-65. PubMed ID: 6150994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropeptides and Alzheimer's disease.
    Gottfries CG; Frederiksen SO; Heilig M
    Eur Neuropsychopharmacol; 1995 Dec; 5(4):491-500. PubMed ID: 8998402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre- and postsynaptic neurochemical alterations in Alzheimer's disease.
    Reisine TD; Yamamura HI; Bird ED; Spokes E; Enna SJ
    Brain Res; 1978 Dec; 159(2):477-81. PubMed ID: 215272
    [No Abstract]   [Full Text] [Related]  

  • 36. Recent research into dementia.
    Wilcock GK
    Age Ageing; 1988 Mar; 17(2):73-86. PubMed ID: 2897154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological markers and the cholinergic hypothesis in Alzheimer's disease.
    Nordberg A
    Acta Neurol Scand Suppl; 1992; 139():54-8. PubMed ID: 1414270
    [No Abstract]   [Full Text] [Related]  

  • 38. Biochemical and neuropeptide alterations in Alzheimer's disease.
    Bissette G; Nemeroff CB
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():33A-34A. PubMed ID: 1354039
    [No Abstract]   [Full Text] [Related]  

  • 39. Biologic markers in Alzheimer's disease.
    Thienhaus OJ; Hartford JT; Skelly MF; Bosmann HB
    J Am Geriatr Soc; 1985 Oct; 33(10):715-26. PubMed ID: 2864367
    [No Abstract]   [Full Text] [Related]  

  • 40. Antemortem laboratory diagnosis of Alzheimer's disease.
    Gauthier S; Robitaille Y; Quirion R; Leblanc R
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):391-403. PubMed ID: 3541044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.